Japan

Daiichi Sankyo & AstraZeneca’s Datopotamab Deruxtecan Recommended for EU Approval After Cutting Disease Progression Risk by 37%

Recommendation based on TROPION-Breast01 results showing Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced risk of disease prog...

 February 03, 2025 | News

GHIT Fund Invests JPY 2 Billion (USD 12.7M) in Diagnostics and Drug Development for NTDs and Malaria

The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 2 billion (USD 12.7 million) in eight projects ...

 January 30, 2025 | News

ThinkCyte Expands Product Line to Advance Drug Discovery and Disease Research Innovation

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced today that it will ...

 January 28, 2025 | News

AB2 Bio and Nippon Shinyaku Forge U.S.-Japan Licensing Deal to Launch Tadekinig Alfa for Rare Hyperinflammatory Syndrome

Agreement grants Nippon Shinyaku an option to acquire exclusive U.S. rights to commercialize AB2 Bio’s Tadekinig alfa to treat Primary Monogenic IL...

 January 28, 2025 | News

Advanced Genomics APAC and Cancer Precision Medicine Partner to Launch GALEAS™ Bladder Cancer Screening Test in Japan

 Advanced Genomics APAC Co., Ltd. (hereinafter referred to as "Advanced Genomics APAC," headquartered in Taiwan, Managing Director: Andy Chang) i...

 January 14, 2025 | News

NEC and Biomy Partner to Advance AI-Powered Digital Pathology for Precision Cancer Care

NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) to form a joint marketing partnership aimed at adv...

 January 10, 2025 | News

Human Metapneumovirus Sparks Concern Across Asia: India Joins Global Vigilance

The detection of Human Metapneumovirus (HMPV) in Karnataka, India, and a rising number of cases across Asia have prompted heightened vigilance among health...

 January 06, 2025 | Analysis

Astellas Pharma Announces NMPA Approval of Zolbetuximab in China for Advanced Gastric and GEJ Cancer

  Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the National Medical Products Administration (N...

 January 06, 2025 | News

JCR Pharmaceuticals and Modalis Therapeutics Advance CNS Gene Therapy Collaboration

JCR Pharmaceuticals Co., Ltd.  and Modalis Therapeutics Corporation  announced that they have validated the initial proof of concept in a jo...

 January 06, 2025 | News

Japan Approves TEPOXX as First Antiviral Treatment for Orthopoxviruses, Including Smallpox, Mpox, and Cowpox

Regulatory decision marks first approval in Japan of an antiviral for the treatment of orthopoxviruses including smallpox, mpox and cowpox Japan Bi...

 January 03, 2025 | News

I Peace Achieves Milestone of Manufacturing 100 GMP-Grade iPS Cell Lines

Leading GMP cell CDMO I Peace, Inc., specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that the n...

 December 31, 2024 | News

Takeda’s HYQVIA Becomes First Facilitated Subcutaneous Immunoglobulin Approved in Japan for Immune Deficiency Disorders

HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] is the First and Only Facilitated Subcutaneous Immunoglobulin (f...

 December 30, 2024 | News

Jadeite Medicines Transfers NDA for Odevixibat in PFIC to Ipsen for Commercialization in Japan

Jadeite Medicines Inc., (Jadeite Medicines) a clinical stage biopharmaceutical company headquartered in Tokyo, Japan (President & CEO, Eiichi Takahashi...

 December 26, 2024 | News

Axcelead Drug Discovery Partners Joins Forces with Astellas Pharma to Advance Targeted Protein Degrader Research

Axcelead Drug Discovery Partners, Inc.  announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Ch...

 December 26, 2024 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close